title: Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research.
abstract: Topical vaginal microbicides have been considered a promising option for preventing the male-to-female sexual transmission of HIV; however, clinical trials to date have not clearly demonstrated robust and reproducible effectiveness results. While multiple approaches may help enhance product effectiveness observed in clinical trials, increasing the drug exposure in lower genital tract tissues is a compelling option, given the difficulty in achieving sufficient drug exposure and positive correlation between tissue exposure and microbicide efficacy. Since many microbicide drug candidates are substrates of transporters and/or metabolizing enzymes, there is emerging interest in improving microbicide exposure and efficacy through local modulation of transporters and enzymes in the female lower genital tract. However, no systematic information on transporter/enzyme expression is available for ectocervical and vaginal tissues of premenopausal women, the genital sites most relevant to microbicide drug delivery. The current study utilized reverse transcriptase polymerase chain reaction (RT-PCR) to examine the mRNA expression profile of 22 transporters and 19 metabolizing enzymes in premenopausal normal human ectocervix and vagina. Efflux and uptake transporters important for antiretroviral drugs, such as P-gp, BCRP, OCT2, and ENT1, were found to be moderately or highly expressed in the lower genital tract as compared to liver. Among the metabolizing enzymes examined, most CYP isoforms were not detected while a number of UGTs such as UGT1A1 were highly expressed. Moderate to high expression of select transporters and enzymes was also observed in mouse cervix and vagina. The implications of this information on microbicide research is also discussed, including microbicide pharmacokinetics, the utilization of the mouse model in microbicide screening, as well as the in vivo functional studies of cervicovaginal transporters and enzymes.
authors.affiliation: 1 Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh , Pittsburgh, Pennsylvania.
authors.forename: Tian
authors.initials: T
authors.lastname: Zhou
authors.forename: Minlu
authors.initials: M
authors.lastname: Hu
authors.forename: Marilyn
authors.initials: M
authors.lastname: Cost
authors.forename: Samuel
authors.initials: S
authors.lastname: Poloyac
authors.forename: Lisa
authors.initials: L
authors.lastname: Rohan
mesh_terms: D000287:Administration, Topical; D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004798:Enzymes / Q000096:biosynthesis*; D005260:Female; D020869:Gene Expression Profiling; D005836:Genitalia, Female / Q000201:enzymology / Q000502:physiology*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D026901:Membrane Transport Proteins / Q000096:biosynthesis*; D051379:Mice; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000890:Anti-Infective Agents; D004798:Enzymes; D026901:Membrane Transport Proteins; D012333:RNA, Messenger